Trump’s FDA Pick Faces Republican Resistance Over Vaccine Role
Heidi Overton’s nomination to lead the FDA immediately drew resistance from the Republican chair of the Senate health committee, putting vaccine policy and management experience at the center of her confirmation fight.
Senate Health Panel Chairman Voices Strong Reservations About F.D.A. Nominee
Trump nominates policy aide Overton to lead FDA
Trump picks White House ally Overton to lead embattled FDA
Trump Taps White House Advisor to Run FDA After Turmoil
Trump announces on Truth Social he will nominate Dr. Heidi Overton to lead FDA
A nomination lands in an unsettled agency
President Donald Trump said Wednesday that he will nominate White House health-policy aide Heidi Overton as commissioner of the Food and Drug Administration. The physician and deputy director of the Domestic Policy Council would succeed Marty Makary, who resigned in May, subject to Senate confirmation.apnews +1
Overton would inherit an agency strained by layoffs, senior departures and abrupt policy shifts. Drugmakers and investors have sought greater consistency in regulatory decisions, while an RBC Capital Markets analyst said her limited drug-regulation experience leaves her likely impact on medicine reviews uncertain.biopharmadive
Vaccine policy complicates the path to confirmation
The sharpest early resistance came from Republican Sen. Bill Cassidy of Louisiana, the Senate health committee chair. Cassidy said Overton's lack of managerial experience was ill-suited to an agency with staffing and morale problems, and called her role in a recent childhood-vaccine order “almost disqualifying.”thehill +1
Overton stood with Trump when he signed the August 10 order seeking to reduce and separate parts of the childhood vaccination schedule. Medical groups challenged the policy's scientific basis, and Cassidy's criticism makes her confirmation hearing more than a routine test despite Republicans' Senate control.apnews +1
Her record is also likely to focus attention on reproductive health. Before joining the administration, Overton was chief policy officer at the conservative America First Policy Institute and publicly celebrated the 2022 Supreme Court ruling that overturned Roe v. Wade. The FDA is reviewing the abortion drug mifepristone as Republicans press to restrict rules allowing it to be mailed after telehealth prescriptions.nbcnews +1
Industry wants predictability while policy fights loom
The next commissioner will confront unfinished work on drug approvals, food safety, vaping, vaccines and ultraprocessed foods. Makary's tenure ended amid complaints about reversals involving rare-disease treatments and departures among senior officials, leaving companies and patient groups looking for a steadier regulatory process.apnews +1
Medical-device trade group AdvaMed offered a supportive response, saying Overton's medical and public-health background could help preserve transparency, consistency and predictability in device reviews.advamed Health Secretary Robert F. Kennedy Jr. also praised her judgment and commitment, tying the choice to the administration's “Make America Healthy Again” agenda.apnews
That coalition does not erase the competing demands ahead. Traditional Republicans favor lighter regulation, Kennedy's allies often take a more anti-corporate position, and senators are preparing to scrutinize Overton's vaccine and abortion views. Her first challenge is therefore confirmation itself; the next is demonstrating that scientific review can remain stable while the White House pushes rapid changes across health policy.apnews +1